- Home
- GRDN vs BSTZ Comparison
GRDN vs BSTZ Comparison
Compare GRDN & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- BSTZ
- Stock Information
- Founded
- GRDN 2004
- BSTZ 2019
- Country
- GRDN United States
- BSTZ United States
- Employees
- GRDN N/A
- BSTZ N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- BSTZ Trusts Except Educational Religious and Charitable
- Sector
- GRDN Consumer Staples
- BSTZ Finance
- Exchange
- GRDN Nasdaq
- BSTZ Nasdaq
- Market Cap
- GRDN 1.8B
- BSTZ 1.5B
- IPO Year
- GRDN 2024
- BSTZ N/A
- Fundamental
- Price
- GRDN $30.29
- BSTZ $22.50
- Analyst Decision
- GRDN Strong Buy
- BSTZ
- Analyst Count
- GRDN 2
- BSTZ 0
- Target Price
- GRDN $24.50
- BSTZ N/A
- AVG Volume (30 Days)
- GRDN 313.2K
- BSTZ 303.2K
- Earning Date
- GRDN 11-11-2025
- BSTZ 01-01-0001
- Dividend Yield
- GRDN N/A
- BSTZ 8.31%
- EPS Growth
- GRDN N/A
- BSTZ N/A
- EPS
- GRDN N/A
- BSTZ 0.71
- Revenue
- GRDN $1,326,604,000.00
- BSTZ N/A
- Revenue This Year
- GRDN $16.17
- BSTZ N/A
- Revenue Next Year
- GRDN $2.31
- BSTZ N/A
- P/E Ratio
- GRDN N/A
- BSTZ $26.69
- Revenue Growth
- GRDN 18.53
- BSTZ N/A
- 52 Week Low
- GRDN $14.16
- BSTZ $14.11
- 52 Week High
- GRDN $30.27
- BSTZ $19.43
- Technical
- Relative Strength Index (RSI)
- GRDN 82.92
- BSTZ 65.50
- Support Level
- GRDN $27.35
- BSTZ $21.62
- Resistance Level
- GRDN $28.98
- BSTZ $22.35
- Average True Range (ATR)
- GRDN 1.00
- BSTZ 0.34
- MACD
- GRDN 0.21
- BSTZ 0.07
- Stochastic Oscillator
- GRDN 99.81
- BSTZ 95.65
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.